Stephanie Jones MBChB MRCP MRCGP BClinSci DFSRH FFPM
Chief Medical Officer
Pharmora
Macclesfield, United Kingdom
1 profile visit
I am CMO for Pharmora, which I founded in 2010. We provide strategic medical oversight for clinical development planning, and clinical trial medical monitoring. Our goal is to facilitate innovation and help new products reach the patients who need them.
Pharmora provides assured, global medical review services for the clinical development, marketing and safety surveillance of medical products, from the first clinical trials to ongoing commercialisation. We deliver the capabilities of a Consultantwith the scalability & flexibility of a Service Provider, wrapped in the security of full Quality Assurance.
Consultant pharmaceutical physician with decades of experience across clinical development and patient safety, spanning numerous therapy areas in regulatory and medical affairs.
I am CMO for Pharmora, which I founded in 2010, based in our UK HQ in Macclesfield, Cheshire. (We also have an EU office).
I am an Educational Supervisor for the Faculty of Pharmaceutical Medicine of the UK Royal Colleges of Physicians, and Visiting Lecturer for King's College London. My main role in Pharmora is training, mentoring and supporting our highly skilled team of scientists and medics, to make sure we help our clients achieve their goals, and I oversee all the contracts with our clients.
My passion is to do the best I can in everything I do.
If you are planning to investigate your innovation in clinical trials we can help you plan your clinical development programme and navigate the complex regulatory environment, to make the most of every data point, and help you achieve your goals.
Pharmora can assess the data to identify and flag to you any gaps or inconsistencies. We clarify remaining steps required to develop the product for market, providing therapy area competitor context, helping you to understand the risks and opportunities.
We can help you prepare your data room and presentations to attract potential investors and co-development partners, or compile your key messages to improve your chances of success for grant funding applications.